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Abstract
Background: Neurotrophins are important regulators of growth and regeneration, and acutely, they can
modulate the activity of voltage-gated ion channels. Previously we have shown that acute brain-derived
neurotrophic factor (BDNF) activation of neurotrophin receptor tyrosine kinase B (TrkB) suppresses the
Shaker voltage-gated potassium channel (Kv1.3) via phosphorylation of multiple tyrosine residues in the N
and C terminal aspects of the channel protein. It is not known how adaptor proteins, which lack catalytic
activity, but interact with members of the neurotrophic signaling pathway, might scaffold with ion channels
or modulate channel activity.
Results: We report the co-localization of two adaptor proteins, neuronal Src homology and collagen
(nShc) and growth factor receptor-binding protein 10 (Grb10), with Kv1.3 channel as demonstrated
through immunocytochemical approaches in the olfactory bulb (OB) neural lamina. To further explore the
specificity and functional ramification of adaptor/channel co-localization, we performed
immunoprecipitation and Western analysis of channel, kinase, and adaptor transfected human embryonic
kidney 293 cells (HEK 293). nShc formed a direct protein-protein interaction with Kv1.3 that was
independent of BDNF-induced phosphorylation of Kv1.3, whereas Grb10 did not complex with Kv1.3 in
HEK 293 cells. Both adaptors, however, co-immunoprecipitated with Kv1.3 in native OB. Grb10 was
interestingly able to decrease the total expression of Kv1.3, particularly at the membrane surface, and
subsequently eliminated the BDNF-induced phosphorylation of Kv1.3. To examine the possibility that the
Src homology 2 (SH2) domains of Grb10 were directly binding to basally phosphorylated tyrosines in
Kv1.3, we utilized point mutations to substitute multiple tyrosine residues with phenylalanine. Removal of
the tyrosines 111–113 and 449 prevented Grb10 from decreasing Kv1.3 expression. In the absence of
either adaptor protein, channel co-expression reciprocally down-regulated expression and tyrosine
phosphorylation of TrkB kinase and related insulin receptor kinase. Finally, through patch-clamp
electrophysiology, we found that the BDNF-induced current suppression of the channel was prevented by
both nShc and Grb10.
Conclusion: We report that adaptor protein alteration of kinase-induced Kv1.3 channel modulation is
related to the degree of direct protein-protein association and that the channel itself can reciprocally
modulate receptor-linked tyrosine kinase expression and activity.
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Background
Voltage-dependent potassium (Kv) channels are regula-
tors of neuronal excitability. The channels are responsible
for maintaining the resting potential of cells, they deter-
mine the width and maximum amplitude of the action
potential, and they govern the interpulse interval or tim-
ing patterns of firing in order to relay sensory information
to the brain or coordinate motor output [1,2]. As recently
reviewed by Kaczmarek [3], Kv channels may lead a "dou-
ble life" by possessing non-conducting functions, which
allow them to participate in coupled biochemical reac-
tions or communicate directly with cytoplasmic and
nuclear signaling pathways. Kv1.3, a member of the
Shaker  subfamily of Kv channels, is particularly well
poised to participate in multiple cell signaling pathways
given a number of molecular motifs that serve as protein-
protein interaction domains in the N and C terminal
aspects of the channel protein (Fig. 1). Multiple and dif-
ferent combinations of tyrosine residues become phos-
phorylated upon activation of cellular and receptor
tyrosine kinase signaling cascades to elicit changes in ion
channel current magnitude, inactivation kinetics, or
cumulative/use-dependent inactivation [4-9]. Further lev-
els of complexity exist, however, because the channel is
not just a substrate for tyrosine phosphorylation. The
phosphorylated tyrosine residue(s) now become recogni-
tion motifs for a variety of src homology 2 (SH2) domain
containing proteins [10] that are down-stream signaling
molecules, or adaptor proteins, without catalytic activity
[11], and which functionally subserve to "modulate the
modulation" [12,13]. Two proline-rich domains have
been shown to serve as phosphorylation-independent
binding domains for src homology 3 (SH3) containing
proteins and ubiquitin ligases to change Kv1.3 channel
clustering and surface expression [14]. Gene-targeted
deletion of Kv1.3 demonstrates that the channel's associ-
ated scaffold of kinases and adaptor proteins becomes
unbalanced in the absence of the channel gene, whereby
there is a significant increase in the expression of these
modulatory cell signaling proteins, including neuro-
trophin receptor tyrosine kinase B (TrkB), the cellular
kinase Src, the adaptor proteins 14-3-3, neuronal Src
homology and collagen (nShc), postsynaptic density pro-
tein-95 (PSD-95), and the growth factor receptor-bound
protein 10 (Grb10) [15]. Because Kv1.3 protein has an
abundance of molecular modules for protein-protein
interactions (Fig. 1), it is not surprising to discover a diver-
sity of non-conducting functions following targeted dele-
tion of the core of the scaffold (the channel protein)
[15,16].
This study focuses upon two adaptor proteins enriched in
the olfactory bulb, namely Grb10 and nShc. The adaptor
protein Grb10 is a member of a superfamily of adaptor
proteins that also includes Grb7, Grb14, and Mig-10 [17].
The characterization of conserved molecular architecture
of this family has shown that members all contain a C-ter-
minal SH2 domain, a central segment containing a pleck-
strin homology domain (PH domain), and a principle
binding region for association with insulin-like growth
factor receptor type 1 that also acts to stabilize insulin
receptor kinase (IR) binding to the SH2 domain (Fig. 1).
The N terminal domain of Grb10 is less well conserved
but contains multiple PXXP domains that serve as puta-
tive binding sites for SH3 domain containing proteins
[18] (Fig. 1). While Grb10 was originally discovered to be
an interacting protein with the epidermal growth factor
receptor (EGF-R) [19,20] and later found to be a negative
Cartoon schematic of important regulatory structures in  Kv1.3 ion channel, neurotrophin receptor tyrosine kinase B  (TrkB), and the adaptor proteins, growth factor receptor  binding protein (Grb10) and neuronal and Src homology and  collagen (nShc) Figure 1
Cartoon schematic of important regulatory struc-
tures in Kv1.3 ion channel, Neurotrophin receptor 
tyrosine kinase B (TrkB), and the adaptor proteins, 
growth factor receptor binding protein (Grb10) and 
neuronal and Src homology and collagen (nShc). 
Brain-derived neurotrophic factor (BDNF) binds to TrkB, 
which induces receptor dimerization, autophosphorylation of 
multiple Y residues in the β chains, and subsequent phospho-
rylation of the Kv1.3 downstream substrate. Site-directed 
mutagenesis has been used to map the molecular targets for 
phosphorylation of the channel via activation of insulin recep-
tor kinase (+), Src kinase (*), or TrkB (#). ● = Tyrosine (Y) 
to phenylalanine (F) point mutations made to eliminate vari-
ous phosphorylation recognition motifs. Proline-rich PXXP 
domains in channel and adaptors as noted that are known to 
bind to SH3- domain containing proteins. Note SH2 domains 
of Grb10 and nShc that recognize Y-phosphorylated residues 
in protein partners. Shc binding site on TrkB (Y490) is also 
noted (TrkBShc-). SH3 = Src homology 3 domain, SH2 = Src 
homology 2 domain, PTB = protein tyrosine binding, PH = 
pleckstrin homology domain, BPS = binding phosphorylated 
substrate, PLC = phospholipase C, β = beta subunit.BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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regulator of the IR via ubiquitination [21-24], it may also
interact with other RTKs. Grb10 has been linked with
human growth retardation and type 2 diabetes when
upregulated or mutated [25,26], which alters Grb10 pro-
tein-protein interactions. The adaptor protein nShc
belongs to a family that includes three major genes, ShcA
(Shc), ShcB (Sck), and ShcC (nShc, or neuronal Shc). All
Shc isoforms possess two distinct domains that bind
phosphotyrosine containing sequences, namely, the
phosphotyrosine binding domain (PTB) and the SH2
domain, and a central domain (called CH1) that contains
multiple tyrosine phosphorylation sites [27,28] (Fig. 1).
nShc is specifically enriched in adult brain and has been
found to direct survival and phenotypic maturation of
neurons via association with neurotrophin receptors [29-
32]. More recently, nShc has been also implicated in the
modulation of hippocampal synaptic plasticity via modu-
lation of the NMDA receptor, independent of neuro-
trophin receptor signaling [33].
Previous site-directed mutagenesis studies in heterolo-
gous expression systems, have demonstrated that BDNF-
activation of TrkB kinase phosphorylates Kv1.3 at three
tyrosine (Y) residues or clusters in the N- and C-termini of
the channel, Y111–113, Y137, Y479, to cause suppression of
current magnitude without changes in channel inactiva-
tion or deactivation kinetics [9]. Our current strategy was
to co-express channel and kinase with one of two adaptor
proteins that varied in their reported interactions: (1) an
adaptor protein that was not known to directly associate
with the neurotrophin receptor or the channel (Grb10),
and (2) an adaptor protein that was known to bind to Y490
(NPQpY motif) of the neurotrophin receptor (nShc).
Unexpectedly, we discovered that nShc adaptor proteins
reportedly characterized to interact with RTKs also used
Kv1.3 channel for a binding partner directly. Grb10 did
not interact with either the channel or kinase, but could
indirectly modulate the channel by changing its surface
expression. In native OB, however, both adaptor proteins
co-IP with Kv1.3 and TrkB kinase. Our data suggest that
there is a complex regulation between the channel, the
kinase, and adaptor proteins such that the expression of
Kv1.3 down regulates that of TrkB kinase, while the
expression of Grb10 likely acts to induce ubiquitination
of the channel thus decreasing channel surface expression.
Results
Co-localization of adaptor proteins and Kv1.3 channel in 
the olfactory bulb
Although the goal of our study was to define the molecu-
lar targets for interaction of Kv1.3 plus TrkB kinase in the
presence of adaptor proteins using a well-defined heterol-
ogous expression system (HEK 293 cells), it was impor-
tant to ascertain the physiological significance of such
interactions by first exploring the potential co-localiza-
tion of the adaptor proteins with the channel in native
brain. Kv1.3 has a limited distribution in the central nerv-
ous system, where it has been studied primarily in regions
of highest expression, namely in the olfactory bulb (OB),
the olfactory cortex, and the dentate gyrus of the hippoc-
ampus [34]. We have previously reported the expression
of several adaptor proteins (nShc, Grb10, 14-3-3, and
PSD-95) in cytoplasmic lysates of the OB by Western blot
analysis [12,15] as well as the co-localization and co-IP of
the channel and TrkB kinase in the OB and olfactory cor-
tex [35]. Thus, we explored co-localization of Kv1.3 with
that of nShc (Fig. 2) and Grb10 (Fig. 3) in the OB of post-
natal day 20–30 mice where Kv1.3 channel properties are
well characterized [9,36] and it is known that modulation
of Kv1.3 alters olfactory threshold [15]. Kv1.3 and nShc
demonstrated greatest overlap of expression in the periph-
eral structures surrounding the glomeruli (Fig. 2A–C) and
weaker co-localization patterns in the external plexiform
Co-localization of nShc and Kv1.3 in the olfactory bulb of  postnatal mice Figure 2
Co-localization of nShc and Kv1.3 in the olfactory 
bulb of postnatal mice. Ten micron coronal cryosections 
were sequentially, double immunolabeled with α AU13 
(Kv1.3 antiserum, 1:500) and αShc (1:500), and visualized by 
incubation in species-specific fluorophore-conjugated sec-
ondary antibodies where the green channel represents Kv1.3 
channel, the red channel represents Shc adaptor, and the 
merged image (co-localization of proteins) is yellow. Note 
that the channel and adaptor overlap in the peripheral struc-
tures surrounding the glomeruli and in the external plexi-
form layer (EPL), the mitral cell layer (MCL), the internal 
plexiform layer (IPL), and the granule cell layer (GCL). ONL 
= outer nerve layer.BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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layer (EPL), the mitral cell layer (MCL), the internal plexi-
form layer (IPL), and the granule cell layer (GCL)(Fig.
2D–I). Kv1.3 and Grb10 demonstrated greatest overlap of
expression in the IPL and GCL (Fig. 3A–C) and weaker co-
localization patterns in some fibers surrounding the
glomeruli (Fig. 3D–I).
Adaptors can directly co-IP with Kv1.3 channel 
independent of TrkB kinase
Since both adaptors demonstrated a degree of colocaliza-
tion with Kv1.3 in native brain tissue, we sought more rig-
orous conformation for a potential protein-protein
interaction using HEK293 cells in which site specific
mutation of the channel could be performed to map the
molecular targets for channel-adaptor scaffolding. We
have previously demonstrated that BDNF-induced Kv1.3
current suppression is mediated through tyrosine phos-
phorylation of three sites in the N and C termini of the
channel, Y111–113, Y137 and Y449 [9]. Since both nShc and
Grb10 have SH2 domains that could target any or a com-
bination of these tyrosine residues upon BDNF-induced
TrkB phosphorylation, we wanted to test whether either
adaptor protein could associate with the channel under
BDNF-stimulated conditions. As demonstrated in Fig. 4A
(lanes 5–6), immunoprecipitation of myc-tagged Kv1.3
(IP anti-c-myc), followed by Western analysis and blot-
ting for Shc (blot anti-Shc) labels predominantly a single
52 kDa band in HEK 293 cells that were only co-trans-
fected with mycKv1.3 + Shc (no TrkB). Therefore, the
channel and the Shc adaptor protein form a protein-pro-
tein interaction complex independent of BDNF-induced
phosphorylation of the channel or at least in the absence
of TrkB kinase. Inclusion of TrkB kinase or Y490F TrkB
(TrkBShc-) cDNA into the transfection scheme does not
prevent or increase the channel/adaptor interaction (Fig.
4A, lanes 7–10), further exemplifying the lack of require-
ment of TrkB in the channel/adaptor complex. As shown
in Fig. 4B, we were not able to co-immunoprecipitate TrkB
and Grb10 (lanes 9–10) or Kv1.3 and Grb10 (lanes 1–6),
indicating that unlike nShc adaptor protein [29,37],
Grb10 does not (tightly) associate with the kinase. Also,
note the expression of native levels of adaptor proteins,
apparently endogenous to HEK 293 cells in lanes untrans-
fected with Shc or Grb10 cDNA (Fig. 4A, lanes 1–4, Fig.
4B, lane 7).
Adaptor/kinase/channel scaffold can be precipitated from 
olfactory bulb and hippocampus
Given our ability to co-immunoprecipitate nShc and
Kv1.3 channel, we next explored whether the proteins
interacted in native tissue by using two regions known to
express Kv1.3 [34]. As demonstrated in Fig. 5, immuno-
precipitation of Kv1.3, followed by Western analysis and
blotting for anti-TrkB, anti-Shc, or anti-Grb10, labels pro-
tein bands of predicted molecular mass for the kinase, and
adaptors respectively. As we have previously reported for
the olfactory bulb [36], TrkB labeling demonstrated a
greater intensity for the full-length receptor protein (140–
145 kDa) over that of its truncated form (90–95 kDa) that
lacks a kinase domain (Fig. 5A). The predicted molecular
mass for Shc is multiple depending upon the variant (46/
52/66 kDa) and in previous cytosolic fractions we have
observed all three variants in olfactory bulb preparations
[15]. It is interesting that in the HEK 293 cells, the molec-
ular migration was closest to the 52 kDa variant, whereas
in the olfactory bulb, the variant associated with Kv1.3
(66 kDa) was different than those associated with TrkB
(46/66 kDa) (Fig. 5B). Moving to the hippocampus, the
variants (52/66 kDa) forming a protein-protein interac-
tion with Kv1.3 were also different than that in the olfac-
tory bulb (Fig. 5C). It is also noteworthy, that while Grb10
could not be consistently co-immunoprecipitated with
either the kinase nor the channel via heterologous expres-
sion (Fig. 4B), both were complexed with the adaptor pro-
tein in the olfactory bulb and the hippocampus (Fig. 5). It
is possible in the HEK 293 cells that the interaction is at
the limit of our detection. It may also suggest either a a
missing scaffolding component in the HEK 293 cells that
is essential for protein-protein interactions with the
Grb10 adaptor or a different regulation of Grb10 in neu-
rons.
Co-localization of Grb10 and Kv1.3 in the olfactory bulb of  postnatal mice Figure 3
Co-localization of Grb10 and Kv1.3 in the olfactory 
bulb of postnatal mice. As in Fig. 2 with the substitution of 
αGrb10 (1:500). Note that the channel and adaptor overlap 
mainly in the IPL, GCL, and slightly in some fibers surround-
ing the glomeruli.BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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nShc adaptor forms a protein-protein interaction with Kv1.3 channel Figure 4
nShc adaptor forms a protein-protein interaction with Kv1.3 channel. (A) HEK 293 cells were transiently transfected 
with cDNA encoding myc-tagged Kv1.3 (mK) plus TrkB (T) or nShc (S) or triply transfected with channel, kinase, adaptor com-
bination using either wild-type (T) or mutant TrkB kinase (TShc-) lacking the Shc binding site. Forty-eight hour (h) post-trans-
fection, cells were stimulated with 1 ng/ml BDNF (+) or vehicle control (-) for 10 minutes at 37°C. Five to 10 μg of whole-cell 
lysates from each respective transfection condition were separated by SDS-PAGE, electro-transferred to nitrocellulose, and 
probed with αShc (anti-Shc). Upper panel shows representative expression bands for three such experiments in which endog-
enous (lanes 1–4) versus transfected levels (lanes 5–10) of Shc protein are compared. In the lower panel, lysates were immuno-
precipitated (IP) with an antiserum against the myc epitope to pull down Kv1.3 channel protein (anti-myc), separated by SDS-
PAGE and nitrocellulose was probed with αShc (anti-Shc). Note direct co-IP of Shc and Kv1.3 (lanes 5–6) is independent of 
BDNF stimulation. Addition (lanes 7–8) and loss of TrkB Shc binding site (lanes 9–10) does not affect the co-IP. Lower panel 
expression bands are representative of three such experiments. The predicted molecular mass (Mr) for Shc is 46/52/66 kDa. 
(B) Similar experimental paradigm, protocol, notation, and sample size as in (A) but for Grb10 adaptor. Grb10 = G. Top paired 
panels show three repetitions in which myc-tagged Kv1.3 is transfected alone (mK) or including Grb10 (mKG). Lysates were 
probed with αGrb10 (anti-Grb10) to compare endogenous versus transfected levels of Grb10. IP of the channel (anti-myc) fol-
lowed by probing with αGrb10 (anti-Grb10) fails to indicate any channel/adaptor complex. Bottom paired panels demonstrate 
that αGrb10 can effectively be immunoprecipitated (IP: Grb10, blot Grb10, lanes 7–8) but that it also does not co-IP with TrkB 
(lanes 9–10). Mr for Grb10 is 60 kDa.BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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Grb10 decreases surface expression density of the channel
We have previously reported that Kv1.3 channel modula-
tion can be perturbed by adaptor proteins via disruption
of src- or insulin-induced Kv1.3 phosphorylation [12,13].
In the cellular tyrosine kinase signaling pathway (src
kinase), adaptor proteins that do not disrupt tyrosine
phosphorylation have no effect on channel function;
however, those that decrease tyrosine phosphorylation
can relieve kinase-induced current suppression. In the
receptor tyrosine kinase signaling pathway (IR), adaptor
proteins that disrupt tyrosine phosphorylation relieve
both current suppression and simultaneously act to
increase the rate of channel inactivation. For the neuro-
trophin pathway (a different receptor tyrosine kinase), we
questioned how the degree of channel phosphorylation as
modified by an adaptor protein might be linked to func-
tion. Thus, we immunoprecipitated Kv1.3 channel plus
TrkB kinase under various transfection conditions that
included either Shc or Grb10 adaptors (Fig. 6A). Interest-
ingly, inclusion of nShc in the transfection scheme (Kv1.3
+ TrkB + nShc; KTS) increased the Y phosphorylation of
the channel over that observed under the co-transfection
condition alone (Kv1.3 + TrkB; KT) (Fig. 6A, bottom gel,
lanes 7–8 versus lanes 3–4). Moreover, elimination of the
Y490 TrkB site via substitution with TrkBShc- in the chan-
nel/kinase/adaptor transfection scheme (Fig. 6B; mKTShc-
S, top gel, lanes 5–6) completely prevented tyrosine phos-
phorylation of the channel. Basal phosphorylation of
Kv1.3 (- BDNF conditions) was higher than expected or
reported in our previous studies [9,35], but may be attrib-
uted to the solution used as a vehicle carrier (patch solu-
tion) that may have slightly depolarized the cells (Fig. 6A,
lanes 3 versus 4). None the less, all basal phosphorylation
could be completely eliminated in the absence of TrkB
(Fig. 6A, bottom gel, lanes 1–2) or via substitution with a
dead TrkB kinase construct in which the catalytic domain
was truncated (Fig. 6A, bottom gel, lanes 9–10) [37]. Most
interestingly, inclusion of Grb10 in the transfection
scheme (Kv1.3 + TrkB + Grb10) not only completely elim-
inated the Y phosphorylation of the channel over that
observed in the co-transfection condition (Kv1.3 +
TrkB)(Fig. 6A, bottom gel, lanes 5–6 versus lanes 3–4),
blotting the lysates with anti-Kv1.3 to control for expres-
sion of the channel, revealed that Grb10 was greatly
reducing the expression of Kv1.3 (Fig. 6A, top gel, lanes 5–
6). The degree of BDNF-induced Kv1.3 phosphorylation
in each transfection condition was quantified by densit-
ometry, normalized to that of the Kv1.3 channel transfec-
tion alone, and statistically compared in the bar plot of
Fig. 6C (Student's t-test, arc sine transformation for per-
centage data, α ≤ 0.05).
Expression levels of Grb10, Kv1.3, and TrkB are cross-
regulated
To further explore the robustness of our finding of Grb10
downregulation of Kv1.3, we compared the surface frac-
tion of Kv1.3 channels (mycKv1.3) and the total Kv1.3
pool (Kv1.3) in the presence and absence of Grb10. As
shown in Fig. 7A, B both the surface fraction of Kv1.3
channels as well as the total pool of Kv1.3 is dramatically
down regulated by Grb10 adaptor protein (quantitative
densitometry, significantly-different Student's t-test, α ≤
0.05). Grb10 also had the capacity to down regulate Kv1.3
protein expression in the presence of TrkB kinase (Fig.
7B). In conjunction with the ability to downregulate total
channel protein, immunocytochemical experiments dem-
onstrated a significant reduction in fluorescent signal at
the membrane under Grb10 co-transfection conditions
(Fig. 7C). Albeit lack of Grb10/Kv1.3 co-immunoprecipi-
tation in vitro, if Grb10 was downregulating the expres-
sion of Kv1.3 channel via the SH2 recognition domains
on Kv1.3, then substitution of Y to F mutations in the N-
and C-terminal aspects of the channel should completely
eliminate any reduction in expression. Single point muta-
genesis at the selected Y residues of this study does not
alter expression of the derived channel mutants as deter-
mined by either Western analysis or electrophysiology [7].
Western analysis of HEK 293 cells in which Grb10 was co-
transfected with wild-type or various Y to F channel
mutants revealed that residues YYY111–113 and Y449 repre-
sent important residues for regulation between channel
Kv1.3 channel forms protein-protein interactions with both  adaptor proteins in the olfactory bulb and hippocampus Figure 5
Kv1.3 channel forms protein-protein interactions 
with both adaptor proteins in the olfactory bulb and 
hippocampus. (A-B) Olfactory bulb or (C) hippocampus 
lysates were immunoprecipitated with either anti-Kv1.3 (IP: 
anti-Kv1.3) or anti-TrkB (IP: anti-TrkB), separated by SDS-
PAGE, and Western blots were probed (blot) with channel, 
kinase, or adaptor antisera as noted. Mr as specified.BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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Grb10 adaptor decreases TrkB-induced phosphorylation of Kv1.3 while nShc adaptor increases channel phosphorylation Figure 6
Grb10 adaptor decreases TrkB-induced phosphorylation of Kv1.3 while nShc adaptor increases channel phos-
phorylation. (A) HEK 293 cells were transiently transfected with cDNA encoding Kv1.3 (K) or Kv1.3 plus TrkB kinase (T) 
with either Grb10 (G) or nShc (S). A dead TrkB kinase (D) where the catalytic β chain was truncated (see Fig. 1, TrkBTrunc) 
was also incorporated into the transfection design (KDS). Cells were stimulated with vehicle (-) or BDNF (+), and lysates were 
prepared and separated by SDS-PAGE as in Fig. 4. Upper panel shows representative expression bands for three such experi-
ments in which the nitrocellulose was probed with αAU13 to recognize Kv1.3 channel protein (anti-Kv1.3). Note increase in 
Kv1.3 expression with TrkB co-expression and decreased Kv1.3 expression in the Grb10 co-transfection condition. Lower 
panel lysates were IP with αAU13 (anti-Kv1.3) and then nitrocellulose was probed with an antiserum that recognizes tyrosine 
phosphorylated proteins (anti-4G10) to quantify the degree of channel phosphorylation (pKv1.3). The Mr for Kv1.3 ranges 
from 55 to 72 kDa depending upon extent of phosphorylation (< Kv1.3). (B) Same experimental paradigm, protocol, notation 
and sample size as in (A) but substitution of myc-tagged Kv1.3 (mK) to quantify fraction of pKv1.3 at the surface membrane as 
opposed to total cellular channel protein. HEK 293 cells were transiently transfected with cDNA encoding myc-tagged Kv1.3 
(mK) plus nShc (S) and wildtype TrkB (T) or mutantTrkB kinase (TShc-) lacking the Shc binding site. Upper panel lysates were 
IP with αmyc and then nitrocellulose was probed with α4G10 (anti-4G10) to quantify degree of channel phosphorylation 
(pKv1.3). Note loss of pKv1.3 in lanes 5–6 (upper panel) without the Shc binding site, despite expression of the channel in both 
whole cell fraction (middle panel) and membrane fraction (lower panel). (C) Bar graph plot of the mean ± S.E.M. normalized 
immunodensity values of the pKv1.3 labeled band for experiments demonstrated in A. Pixel density ratios (dashed line, 1.0 no 
difference) were generated for BDNF stimulated (+) conditions by normalizing the pixel density for a transfection condition 
(KT, KTG, KTS, or KDS) to that of control K transfection condition (K) within a single autoradiographic film to eliminate vari-
ability introduced by differential exposure times. * = significantly different compared with control K transfection condition, by 
Student's t-test, arc sine transformation for percentage data, α ≤ 0.05.BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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Grb10 protein-protein interactions with Kv1.3 causes decreased channel expression that require multiple Y residues Figure 7
Grb10 protein-protein interactions with Kv1.3 causes decreased channel expression that require multiple Y 
residues. (A) HEK 293 cells were transiently transfected with cDNA encoding Kv1.3 (K) or Kv1.3 plus Grb10 (G) using either 
myc-tagged Kv1.3 (Upper panel) or wildtype Kv1.3 (Lower panel). Lysates were prepared and separated by SDS-PAGE as in 
Fig. 4. The Mr for Kv1.3 ranges from 55 to 72 kDa depending upon extent of phosphorylation (< Kv1.3). (B) Bar graph plot of 
the mean ± S.E.M. normalized immunodensity values of the Kv1.3 labeled band for experiments demonstrated in A and also 
transfection schemes including TrkB kinase (KT, KTG). Pixel density ratios (dashed line) were generated by normalizing to 
control K transfection condition within a single autoradiographic film to eliminate variability introduced by differential expo-
sure times. * = significantly different compared with control K or KT transfection condition, respectively, by Student's t-test, 
arc sine transformation for percentage data, α ≤ 0.05. (C) Representative HEK 293 cells (of 30) transiently transfected with 
myc-tagged Kv1.3 (Myc) alone or plus Grb10 (Myc + Grb10). Channel protein was detected by incubation with anti-myc under 
non-permeabilizing conditions and then visualized with species-appropriate fluorescent-conjugated secondary antiserum. (D) 
(TOP) As in (A) using wildtype (K) or various Y to F point channel mutations or a W to F point channel mutation (W386F 
Kv1.3); transfection scheme was minus (-) or plus (+) Grb10 adaptor. The Mr for Kv1.3 ranges from 55 to 72 kDa depending 
upon extent of phosphorylation (< Kv1.3). (BOTTOM) As in (A) using Kv1.3 or two other Shaker subfamily members; trans-
fection scheme was minus (-) or plus (+) Grb10 adaptor. NOTE: The Western analyses were performed in pairs for each chan-
nel member and therefore are not aligned to a single migration standard; Mr for Kv1.3 (55 to 72 kDa), Kv1.4 (74 kDa), Kv1.5 
(64 kDa), and actin (42 kDa) varied. (E) Bar graph plot of the mean ± S.E.M. normalized immunodensity values for experiments 
demonstrated in (D, TOP). Pixel density ratios (dashed line) were generated as in Part (B) above, by normalizing to control 
transfection condition without Grb10 and comparing within a single autoradiographic film to eliminate variability introduced by 
differential exposure times. * = significantly different compared to minus Grb10 treatment by Student's t-test, Arc sine trans-
formation for percentage data, α ≤ 0.05. (F) Bar graph plot of the mean ± S.E.M. normalized immunodensity values for experi-
ments demonstrated in (D, BOTTOM). Analyses and statistical metric as in E.BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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and adaptor protein (Fig. 7D and 7E). Removal of these
residues prevented Kv1.3 downregulation by Grb10 co-
transfection. Mutation of residues Y137 and Y479 retained
the trend for down-regulation of Kv1.3, thus these resi-
dues are likely not involved in the adaptor's regulation of
channel expression. Next, we tested whether channel con-
ductance was necessary for Grb10 down-regulation of
Kv1.3 by substituting the pore-conducting mutant W386F
Kv1.3 [38,39]. As shown in Fig. 7D and 7E, mutation of
the pore had no effect in the adaptor's ability to down-reg-
ulate Kv1.3 channel expression. Finally, we tested whether
the Grb10 down-regulation of Kv1.3 was specific to this
particular Shaker subfamily member or could be extended
to other potassium channels. Substitution in the transfec-
tion scheme of either Kv1.4 or Kv1.5, two family members
that are also expressed in olfactory bulb neurons [15], elic-
ited no change in channel expression when co-transfected
with Grb10 (Fig. 7D and 7F). Furthermore, expression of
general structural proteins (actin) also demonstrated no
change in expression in conditions of Grb10 transfection.
Adaptor proteins Grb10 and nShc, respectively decreased
and increased the expression of Kv1.3 channel. Of note-
worthy regulation, curiously it was observed that co-trans-
fection with Kv1.3 channel protein decreased both the
expression of TrkB (Fig. 8A, bottom gel, lanes 3–6) as well
as the phosphorylated state of the kinase when stimulated
with BDNF (Fig. 8A, top gel, lanes 3–6). This was not only
true for TrkB, but also was observed for a different, recep-
tor tyrosine kinase (TK). Expression of Kv1.3 channel also
decreased the expression of IR kinase protein and its con-
comitant phosphorylation by insulin (Fig. 8A, left lanes
7–10). The degree of Kv1.3 expression in the presence and
absence of TrkB or IR kinase was quantified by densitom-
etry, normalized to that of the Kv1.3 channel transfection
alone, and statistically compared in the bar plot of Fig. 8B
(Student's t-test, arc sine transformation for percentage
data,  α  ≤ 0.05). These data pose a complex balance
between channel, kinase, and adaptor whereby the level
of an adaptor protein could down or upregulate expres-
sion of the channel, which could in turn, dial in the degree
of phosphorylation of the kinase (that would be regulat-
ing its own neuromodulation).
BDNF-stimulated channel modulation is blocked by Grb10 
and nShc adaptor proteins
If the two adaptor proteins differentially co-immunopre-
cipitated with Kv1.3 channel, one might predict a func-
tional difference in their ability to modulate the channel
as determined through standard patch-clamp electrophys-
iology. HEK293 cells were thus transiently transfected
with Kv1.3 plus TrkB kinase in the presence or absence of
nShc or Grb10 adaptor protein and monitored for modu-
lation of biophysical properties during a twenty minute
acute stimulation with brain-derived neurotrophic factor
(BDNF). Approximately 40 hours post-transfection, mac-
roscopic outward currents were recorded in the cell-
attached configuration. Cells were voltage-clamped at -90
mV and stepped to a depolarizing potential of +40 mV for
1 second to activate Kv1.3. Table 1 reports Kv1.3 peak cur-
rent amplitude, inactivation time constant (τinact), deacti-
vation time constant (τdeact), voltage at half-activation (V1/
Kv1.3 channel co-transfection suppresses receptor tyrosine  kinase (RTK) expression and concomitant phosphorylation Figure 8
Kv1.3 channel co-transfection suppresses receptor 
tyrosine kinase (RTK) expression and concomitant 
phosphorylation. (A) HEK 293 cells were transiently trans-
fected with cDNA encoding TrkB kinase (T) or Insulin recep-
tor kinase (I) minus or plus Kv1.3 channel (KT, KI). Cells 
were stimulated with vehicle (-) vs. BDNF or insulin (+), and 
lysates were prepared and separated by SDS-PAGE as in Fig. 
4. Upper panel lysates were IP with antiserum that recog-
nizes tyrosine phosphorylated proteins (anti-4G10) and then 
were blotted with either αTrkB or αIR to quantify the 
degree of kinase phosphorylation (pIR or pTrkB). Lower 
panel shows representative expression bands for three such 
experiments in which nitrocellulose was probed with either 
αTrkB or αIR to recognize the respective RTK. (B) Bar 
graph of the mean ± S.E.M. normalized immunodensity values 
for either TrkB or IR kinase expression in the presence 
(striped bar) or absence (solid bar) of Kv1.3 co-expression 
under unstimulated or hormone/trophic factor stimulation (+ 
BDNF or + Insulin), respectively. Pixel density ratios (dashed 
line) were generated by normalizing kinase expression levels 
with the channel (KT or KI) to that of control transfection 
condition without Kv1.3 (T or I) and comparing within a sin-
gle autoradiographic film to eliminate variability introduced 
by differential exposure times. * = significantly different com-
pared to kinase alone transfection condition by Student's t-
test, Arc sine transformation for percentage data, α ≤ 0.05.BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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2), and voltage dependence (κ) for a population of
recorded patches under various transfection conditions
pre (time 0) and post (time 20 minutes) growth factor
application. Twenty minute application of BDNF had no
effect on patches transfected with Kv1.3 channel alone
(Table 1). This control confirms that application of ligand
alone in the absence of the receptor (TrkB kinase) fails to
modulate Kv1.3. Inclusion of Kv1.3 plus TrkB signifi-
cantly increased peak current amplitude without altering
kinetic properties (Table 1). Peak current amplitude was
287 +/- 49 pA (n = 4) in the Kv1.3-only control transfec-
tion condition and 551 +/- 198 pA (n = 4) in the Kv1.3
plus TrkB kinase condition, confirming a statistically sig-
nificant 90% increase in Kv1.3 current in the presence of
the kinase (Student's t-test, α ≤ 0.05). We have previously
reported that TrkB kinase co-expression in the absence of
BDNF stimulation increases the channel half-life at the
plasma membrane [35] so the increase in Kv1.3 current
was as expected. Secondarily, these records demonstrate
typical stability of the patch over the recording interval for
the co-transfection condition (time 0 = 551 +/- 198 pA
versus time 20 = 557 +/- 183 pA; Fig. 9A, Table 1). Inclu-
sion of 1 ng/μl BDNF in the patch electrode (see methods
for back-fill protocol) evoked a significant suppression of
peak current amplitude of Kv1.3 to 85% of its original cur-
rent (Fig. 9B; Table 1, paired t-test, α ≤ 0.05) that was
relieved by co-transfection of either adaptor protein (Fig.
9C–D; Table 1). In addition, we noted that initial peak
current amplitude (time 0) of Kv1.3 in the co-transfection
condition (Kv1.3 plus TrkB kinase; 555 +/- 173 pA (n =
7)) was significantly less in the presence of nShc (343 +/-
71 pA (n = 13)) but was unchanged in the presence of
Grb10 (488 +/- 114 (n = 7)) (Table 1). Regardless of the
pre-stimulation peak current, inclusion of either adaptor
protein, prevented BDNF-induced Kv1.3 current suppres-
sion. Fig. 9E is a histogram representation of the normal-
ized (time 20/time 0) BDNF-induced Kv1.3 current
suppression (mean ± standard error of the mean (s.e.m.))
that is relieved in the presence of Shc or Grb10 (* = signif-
icantly-different paired t-test, α ≤ 0.05, N = 4–13). For
Grb10, the relief in BDNF-induced current suppression
appeared to be coincident with a slight shift in Kv1.3 volt-
age dependence. There was a 5 to 10 mV left shift in the
voltage at half-maximum activation (V1/2) in the presence
of TrkB plus Grb10 (but not nShc) as calculated from a
Boltzman fit of the tail currents when cells were held at -
90 mV and stepped to +20 mV in increments of 5 mV
using a pulse duration of 50 ms (Table 1). Because this
was not a robust effect and was somewhat variable even in
the absence of an adaptor protein, this biophysical prop-
erty was not further studied.
nShc signaling at Y490 TrkB is target for blocked 
modulation of Kv1.3 channel
To our knowledge there no reported direct interactions
between TrkB and Grb10, so we focused our study upon
disruption of known targets of Shc binding to TrkB kinase.
The SH2 domain (see Fig. 1) of nShc is known to bind
phosphorylated Y490 TrkB at the NPQpY recognition motif
[40,41]. If the molecular target for nShc perturbation of
BDNF-induced Kv1.3 current suppression was soley Y490
on TrkB kinase, then destruction of this binding site
(called TrkBShc-) should regain BDNF modulation of
Brain-derived neurotrophic factor (BDNF)-induced activa- tion of TrkB causes current suppression of Kv1.3 current  that is blocked by adaptor proteins nShc or Grb10 Figure 9
Brain-derived neurotrophic factor (BDNF)-induced 
activation of TrkB causes current suppression of 
Kv1.3 current that is blocked by adaptor proteins 
nShc or Grb10. (A-D) Human embryonic kidney 293 
(HEK293) cells were transiently transfected with cDNA 
encoding Kv1.3 channel plus TrkB kinase with modified con-
ditions as noted. Macroscopic currents were recorded in the 
cell-attached configuration by holding patches at (Vh) = -90 
mV and stepping to a single depolarizing potential of +40 mV 
(Vc) for 1000 ms at an interpulse frequency of 45 s. Record-
ing pipettes were back-filled with 1 ng/μl BDNF (BDNF) or 
control solution (vehicle) and tip-filled with control patch 
solution to monitor change in kinase activation over time. 
Time 0 = represents current evoked upon stable seal forma-
tion, Time 20 = post-neurotrophin treated patch 20 minutes 
later. (E) Histogram plot of the peak current amplitude for 
various transfection conditions and recordings as in (A-D). 
Data are normalized as a ratio of final current over initial 
current (I20/I0) and are expressed as mean ± standard error 
of the mean (S.E.M.); sample size as indicated. * = statistically 
significant by paired t-test at α ≤ 0.05. Dashed line = ratio of 
1.0 or no change post-neurotrophin stimulation.BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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Kv1.3 (prevent relief of current suppression by adaptor
protein). What we found by substituting the TrkB kinase
mutant construct, however, was an intermediate effect.
Co-transfection of Kv1.3 + TrkBShc- plus nShc cDNA
exhibited BDNF-induced current suppression of Kv1.3
(533 +/- 109 pA (time 0) versus 473 +/- 115 pA (time 20)
that did not reach statistical significance (not significantly
different paired t-test, α ≤ 0.05; n = 10, 89% suppression)
compared with that observed with Kv1.3 + TrkB co-expres-
sion (356 +/- 71 pA (time 0) versus 298 +/- 64 pA (time
20); significantly different paired t-test, α ≤ 0.05; n= 5,
84% suppression) (Table 2, Fig. 10B, C). If, however, we
substituted Grb10 in the transfection scheme instead of
nShc (Kv1.3 + TrkBshc- + Grb10), we observed retention
of BDNF-induced current suppression that was not
relieved by the adaptor protein (533 +/- 122 pA (time 0)
versus 379 +/- 84 pA (time 20); significantly different
paired t-test, α ≤ 0.05; n = 4, 71% suppression) (Table 2,
Fig. 10D). Although Grb10 has never been reported to
directly interact with TrkB kinase signaling cascades, and
we also do not find that this adaptor co-immunoprecipi-
tates with the kinase in vitro (Fig. 4B), residue Y490 of TrkB
kinase is an important target for nShc, and its mutation
appears to somehow uncouple Grb10 modulation of the
channel. With the removal of Y490 of TrkB kinase, Grb10
can no longer relieve BDNF-induced current suppression
of the channel (Fig. 10D and 10G). Interestingly,
although neither adaptor protein induces a change in
peak current amplitude of Kv1.3 alone (Fig. 10E and 10F),
Grb10 also evoked a faster rate of channel inactivation
(762 +/- 151 msec (minus Grb10) versus 553 +/- 46 msec
(plus Grb10) as demonstrated in Fig. 10E and statistically
compared in Table 1.
Discussion
Kv1.3 is a substrate for multiple tyrosine kinase signaling
cascades including IR, TrkB, and src kinase [5,7-9,35,36].
Each exerts the phosphorylation of multiple tyrosine resi-
dues, and different combinations of residues, to produce
a unified response, of Kv1.3 current suppression. Inclu-
sion of adaptor proteins causes perturbation of the chan-
nel current suppression [12,13], and in the case of
neurotrophin signaling, we find that disruption of the
channel modulation is not directly correlated to the extent
of channel phosphorylation. The scenario is more com-
plex. This may be attributed to the fact that the interaction
between kinase and channel is no longer a binary relation-
ship, with the added adaptor having the capacity to bind
to both channel and kinase to elicit different responses.
Not only can an adaptor protein alter how the channel
will respond to neurotrophin-induced current suppres-
sion, the adaptors alter expression levels of the channel
and the channel itself can downregulate TrkB expression
and its phosphorylated state. Such a dynamic equilibrium
Table 1: The effect of adaptor proteins on TrkB kinase-induced Kv1.3 current properties.
Transfection Condition Modulator Peak current
(pA)
τInact
(msec)
τDeact
(msec)
V1/2
(mV)
κ
Kv1.3 BDNF
Pre 287 ± 49 (4) 794 ± 252 31.5 ± 5.4 -38.2 ± 5.8 4.2 ± 0.7
Post 303 ± 68 961 ± 263 38.3 ± 13.2 -41.5 ± 6.8 4.9 ± 1.1
Kv1.3 + Grb10 BDNF
Pre 506 ± 271 (4) 774 ± 110 31.3 ± 4.5 -39.4 ± 6.1 5.4 ± 0.4
Post 498 ± 246 *610 ± 127 34.2 ± 4.7 -41.5 ± 6.8 4.4 ± 2.6
Kv1.3 + nShc BDNF
Pre 543 ± 176 (7) 770 ± 45 32.6 ± 4.3 -45.0 ± 2.5 4.3 ± 0.6
Post 586 ± 107 817 ± 54 31.4 ± 4.0 -41.4 ± 3.3 3.9 ± 0.9
Kv1.3 + TrkB Vehicle
Pre 551 ± 198 (4) 788 ± 186 37.2 ± 3.3 -40.4 ± 5.0 5.1 ± 0.5
Post 557 ± 183 742 ± 130 32.3 ± 3.3 -38.6 ± 5.8 5.4 ± 0.7
Kv1.3 + TrkB BDNF
Pre 555 ± 173 (7) 900 ± 243 36.8 ± 2.9 -36.2 ± 4.6 5.8 ± 1.1
Post *442 ± 173 762 ± 151 38.8 ± 6.7 -40.3 ± 6.7 5.3 ± 1.4
Kv1.3 + TrkB + Grb10 BDNF
Pre 488 ± 114 (7) 862 ± 110 29.3 ± 3.5 -42.6 ± 3.7 6.7 ± 0.6
Post 545 ± 133 *553 ± 46 35.4 ± 5.5 *-54.1 ± 2.8 6.3 ± 1.4
Kv1.3 + TrkB + nShc BDNF
Pre 343 ± 71 (13) 618 ± 67 37.4 ± 3.2 -40.9 ± 1.9 4.4 ± 0.7
Post 381 ± 92 549 ± 68 36.4 ± 2.0 -43.5 ± 2.9 4.4 ± 1.1
HEK 293 cells were transfected with cDNAs encoding Kv1.3 ± TrkB ki nase ± adaptor protein. Several voltage-stimulating paradigms were 
completed (see "Methods") to collect the tabled biophysical properties by cell-attached patch-clamp recording. Mean values (± s.e.m.) for peak 
current amplitude (pA), inactivation time constant (τInact), deactivation time constant (τDeact), voltage at half activation (V1/2), and slope (κ) of the 
voltage dependence were compared across various transfection conditions at the start of the patch recording (Pre) versus twenty minutes 
following 1 ng/μg BDNF (Post) using a paired t-test, α ≤ 0.05. * = Significantly different.BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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between Kv1.3/TrkB/adaptors may allow a full spectrum
of modulation of channel properties dependent upon the
compliment of proteins co-expressed in a neuron at a
given physiological state.
Biochemically, the degree of channel phosphorylation by
BDNF-induced TrkB activation is no longer directly
related to the degree of functional current suppression
when adaptors are added to the mix. This is very different
than what is reported for the cellular tyrosine kinase, Src.
Here, phosphorylation was directly linked to the degree of
current suppression and one could predict the modula-
tion of the selected adaptor protein based upon how it
influenced tyrosine phosphorylation of the channel [12].
This is in stark contrast to RTKs. The addition of nShc to
Kv1.3 plus TrkB transfected conditions induced an
increase in both channel expression as well as BDNF-
induced channel phosphorylation whereas the addition
of Grb10 resulted in the opposite. Despite the fact that the
adaptors evoke an opposite response biochemically, the
functional ramification is identical, the prevention of
BDNF-induced current suppression. In fact, nShc/Grb
have structurally similar SH2 domains whereas PSD-95
lacks such phosphorylation-dependent interactive
domains [13], and yet each has the capacity to function-
ally perturb the BDNF-induced current suppression. This
might suggest that direct interaction of the adaptor and
the channel may play a predominant role in preventing
kinase modulation and that changed phosphorylation is a
secondary effect. In the case of the two SH2 domain con-
taining adaptor proteins, nShc and Grb10, binding of Y490
TrkB by nShc is an additional key regulatory site impact-
ing modulation of the channel. Certainly there are endog-
enous levels of both nShc and Grb10 expressed in HEK
293 cells, thus our Kv1.3 + TrkB conditions are not com-
pleted devoid of adaptor protein, however, when nShc is
co-transfected with these conditions, binding of Y490 TrkB
induces a block of BDNF-induced channel suppression.
Kv1.3 channel expression is changed in the presence of
TrkB kinase without BDNF stimulation and now we can
also see that Grb10 adaptor significantly modifies surface
expression of Kv1.3. With TrkB kinase co-expression, there
is a correlate increase in channel surface expression,
increase in channel protein expression, and increase in
channel macroscopic current [35]. Interestingly, with
Grb10 co-expression (also not BDNF dependent) there is
oppositely a decrease in channel surface expression, a
decrease in protein expression of the channel, but no
change in channel macroscopic current, rather an
increased rate of channel inactivation. The adaptor/chan-
nel do not form a complex in vitro that we can detect, nev-
ertheless, co-expression apparently changes surface
distribution and channel density but not current magni-
tude or conduction. This would imply that there must be
MANY Kv1.3 channels that are not contributing to cur-
rent. Such a pool of silent or "sleeping channels" has been
reported for specific Kv subfamily members (Kv6 and Kv9
family members) [42,43] and uncovered for other potas-
sium channels during FRAC (functional recovery after
chemobleaching) [44]. Our data [35] and that reported by
Sun et al. [44] support that molecular/protein density of a
channel may not always exhibit linearity with functional
density.
Mutation of Y490 TrkB Shc binding site differentially affects  block of TrkB-induced current suppression of Kv1.3 current  by adaptor proteins nShc and Grb10 Figure 10
Mutation of Y490 TrkB Shc binding site differentially 
affects block of TrkB-induced current suppression of 
Kv1.3 current by adaptor proteins nShc and Grb10. 
(A-F) Same experimental paradigm, notation, and analysis 
protocol as Fig. 9 with the substitution of mutant TrkB kinase 
(TrkBShc-) in which the recognition site (Y490) for nShc bind-
ing was altered by point mutation to F. Note that TrkB-
induced current suppression observed in (B) is still blocked 
by co-transfection of nShc in (C) but not with Grb10 (D). 
Note that Grb10 co-transfection (E) but not nShc co-trans-
fection (F) with Kv1.3 alone induced an increased rate of 
inactivation. (G) Histogram plot of the peak current ampli-
tude for various transfection conditions and recordings as in 
(A-F). Data are normalized as a ratio of final current over ini-
tial current (I20/I0) and are expressed as mean ± S.E.M.; sam-
ple size as indicated. * = statistically significant by paired t-
test at α ≤ 0.05. Dashed line = ratio of 1.0 or no change 
post-neurotrophin stimulation.BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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Based upon the crystal structure of Grb10 SH2 domain
determined at 1.65 Å resolution, it is suggested that bind-
ing of Grb10 is dimeric, using turn containing phosphoty-
rosine sequences [45]. It is unknown (but doubtful) if the
Kv1.3 channel contains turn containing phosphotyrosine
motifs unless the tetrameric structure of the subunits per-
mitted such an alignment, which would be contrary to
positioning of the α transmembrane helices 1 and 6 for
Kv1.2, a Shaker family member for which crystal structure
has been reported [46]. On the basis of structural analysis
and previous biochemical studies for the adaptor, Grb10
and Grb14 have a partially impaired ability to bind phos-
photyrosine-containing ligands due to a non-glycyl resi-
due at the end of the BD loop and lack of a P + 3 binding
pocket [47]. These combined data are consistent with our
findings that we cannot detect Grb10 and Kv1.3 co-immu-
noprecipition in vitro, albeit the fact that channel/adaptor
functional interactions appear to modulate channel
expression and can be found as a complex in unstimu-
lated native tissues. The fact that mutation of several Y res-
idues on the N and C terminal aspects of the channel
clearly perturbs the negative modulatory affect of Grb10
on channel expression, indicates a specific modulatory
role that does not require tight association. Moreover, the
modulation does not require channel activity, or at least
functional ion conductance. While all Y to F channel
mutations blocked Grb10 down regulation of Kv1.3
expression, YYY111-113FFF Kv1.3 and Y449F Kv1.3
appear to be the most robust at blocking down regulation.
Both of these sites (along with Y137) were previously
reported as targets for BDNF-induced Kv1.3 current sup-
pression and phosphorylation [9] but only Y449 has a large
hydrophobic M downstream of the phosphotyrosine,
reported as a preferred Grb motif [48].
It has previously been reported that the E3 ubiquitin pro-
tein ligase called Nedd4-2 regulates voltage-gated ion
channels, including Nav, Kir, and Kv family members [49]
via targeting phosphotyrosine motifs located in the C-ter-
minal aspect of the channel. It has also been demon-
strated that the SH2 domains of Grb10 form a constitutive
complex with Nedd4-1 so as to mediate ligand-dependent
ubiquitination of IGF-IR [17]. Since co-expression of
Nedd4-2 with Kv1.3 in Xenopus oocytes induces a strong
suppression of Kv1.3 current [14] we conjecture that
Grb10 might bind to endogenous Nedd4-2 in our system
to cause ubiquitination of Kv1.3 and/or TrkB kinase. This
might explain a potential mechanism for decreased Kv1.3
surface expression in the presence of Grb10 and correlate
decreased channel tyrosine phosphorylation.
We have shown that TrkB and Grb10 act as modulators of
channel expression, while others have demonstrated that
the Grb10 adaptor acts as a negative modulator of IR
kinase activity (reviewed by Holt and Siddle [47]). Ramos
et al. [50] elucidated the mechanism by which the SH2
and binding phosphorylated substrate (BPS) domains of
Grb10 might induce proteasomal degradation of the IR
and subsequent inhibition of its downstream signaling
pathways. The question arises as to whether the adaptor or
kinases themselves are regulated and if so, how? Our data
demonstrate that there is a reciprocal regulation of RTK
phosphorylation activity and expression in the presence
of Kv1.3. Holmes et al. [4] similarly reported that treat-
ments that induce membrane hyperpolarization (K chan-
nel activity) markedly attenuate tyrosine phosphorylation
catalyzed by cellular tyrosine kinases. Unlike their report,
centralizing on reciprocal downregulation of Kv1.3 and
cellular TKs, our data demonstrate that both TrkB and IR
kinase protein levels are reduced when co-expressed with
Table 2: The effect of adaptor protein signaling at Y490 TrkB for Kv1.3 current properties.
Transfection Condition Peak Current
(pA)
τInact
(msec)
τDeact
(msec)
Kv1.3 + TrkB
Pre 356 ± 71 (5) 697 ± 130 32.2 ± 2.1
Post *298 ± 64 780 ± 59 24.2 ± 2.9
Kv1.3 + TrkBShc-
Pre 372 ± 144 (3) 693 ± 45 31.8 ± 3.3
Post 386 ± 140 843 ± 114 26.5 ± 3.7
Kv1.3 + TrkBShc- + nShc
Pre 533 ± 109 (10) 1070 ± 163 31.2 ± 4.3
Post 473 ± 115 1040 ± 196 35.3 ± 3.8
Kv1.3 + TrkBShc- + Grb10
Pre 533 ± 122 (4) 894 ± 173 29.0 ± 1.6
Post *379 ± 84 660 ± 229 32.6 ± 7.8
HEK 293 cels were transfected with cDNAs encoding Kv1.3 +TrkB kinase or TrkBShc- (Y490 mutation) ± adaptor protein. Several voltage-
stimulating paradigms were completed (see "Methods") to collect the tabled biophysical properties by cell-attached patch-clamp recording. BDNF 
stimulation, notations, and statistical analysis as in Table 1.BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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Kv1.3, which then in turn, decreases the total amount of
kinase phosphorylation. At the same time, we also
observe that both nShc and Grb10 adaptor protein expres-
sion is reduced when co-expressed with Kv1.3 (data not
shown), and that the expression of both adaptors is
increased in Kv1.3-null mice [15], offering another tier of
regulation of the channel/kinase/adaptor interaction
involving receptor-linked as opposed to cellular tyrosine
kinases. Another suggested method in which Grb10
action might be terminated is via phosphorylation; in its
inactive state it is thought to form tetramers [51,52].
Although we did not test whether Grb10 was phosphor-
ylated in channel/kinase/adaptor transfected conditions
under BDNF-stimulated conditions (Fig. 6), this certainly
did not functionally affect downregulation of channel
expression.
Grb10 appears to be promiscuous in interacting with mul-
tiple receptor and non-receptor TKs and other signaling
proteins in vitro [47], therefore, gene-targeted deletion of
the adaptor could afford physiological relevance to many
of these interactions. Grb10-null mice have dispropor-
tionate overgrowth of the embryo and placenta, imbal-
anced glucose homeostasis, and are approximately thirty
percent larger at birth [24,25,53]. This is an interesting
phenotype given the fact that Kv1.3-null mice, oppositely,
are resistant to diet-induced obesity, are smaller and phys-
iologically thinner than age-matched wild-type animals,
and have increased mobility and metabolism [15,54,55] –
while having an increased expression of Grb10 protein
that reinforces its function as a growth inhibitor [47].
In heterologous expression systems and in vivo, Shc adap-
tor protein can bind directly to the channel (where it does
not alter function or expression). Shc can also bind to
TrkB at Y490 to increase phosphorylation of Kv1.3 and
relieve BDNF-induced current suppression. To what
extent is this mimicked in native olfactory bulb neurons
(OBNs)? We know that exogenous application of BDNF
to native OBNs [9,36], where Shc and TrkB are both
present [12,15], causes an increase in Kv1.3 tyrosine phos-
phorylation and current suppression that is significantly
greater than what we observe in heterologous expression
systems [35] (typically 60% (mice) to 40% (rats) of mitral
cell outward current is suppressed by acute BDNF stimu-
lation). We also know that RTKs explicitly target Kv1.3,
because in mice with Kv1.3 gene-targeted deletion, nei-
ther insulin nor BDNF has any affect on mitral cell cur-
rent. Thus, there is a divergence in gain strength between
HEK 293 cells and OB neurons for neurotrophic factor sig-
naling that might lie at a missing adaptor protein not
mimicked in the HEK 293 cell system, a lesser abundance
of inhibitory adaptor proteins, or perhaps another regula-
tory molecule as yet not accounted for.
Conclusion
In native OB, adaptor proteins may change with develop-
mental profile, regeneration, or disease [26,28,32,56,57]
– hence expression patterns of co-localization may be
non-static, which would result in state-dependent channel
properties. For example, it is well documented that neuro-
trophins are altered with injury [58-60] and that insulin is
modified with metabolic state and meals [61], while both
are modified with growth or development [62-64]. There-
fore, the conductance through a Kv1.3 channel, which
underlies the shape and frequency of the action potential
output of the OB, would inherently be modified by
dynamic change in physiological state. This in turn might
predict that odor perception is very state dependent as dic-
tated by its microenvironment of protein partners and
adaptors that would influence a major voltage-gated ion
channel in this system.
Methods
Solutions and reagents
Human embryonic kidney cell (HEK 293) patch solution
contained (in mM): 30 KCl, 120 NaCl,10 4-(2-hydrosye-
thyl)-1-peperazineethanesulfonic acid (HEPES), and 2
CaCl2 (pH 7.4). HEK 293 cell recording bath solution
contained (in mM): 150 KCl, 10 HEPES, 1 EGTA, and 0.5
MgCl2 (pH 7.4). Cell lysis buffer contained (in mM): 25
tris (hydroxymethyl) aminomethane (pH 7.5), 150 NaCl,
150 NaF, 0.5 EDTA, and 1.0% Triton X-100 (pH 8.0). Pro-
tease and phosphatase inhibitor (PPI) solution was added
to the lysis buffer just prior to use for a final concentration
as follows: 1 μg/ml pepstatin A, 1 μg/ml leupeptin, 2 μg/
ml aprotinin, 10 μg/ml phenylmethylsulfonyl fluoride,
and 10 mM Na3VO4. Nonidet-NP40 protease and phos-
phataseinhibitor (NP40 PPI) solution was prepared in the
same PPI solution as above but contained (in mM): 20
Tris base (pH 7.5), 150 NaCl, 1% nonidet-NP40 and 10%
glycerol. Homogenization buffer contained (in mM): 320
sucrose, 10 Tris, 50 KCl, 1 ETDA (pH 7.8). Wash buffer
contained (in mM): 25 Tris base (pH 7.5), 150 NaCl, 150
NaF, 0.5 EDTA and 0.1% Triton X-100. Tris stripping
buffer (TSB) contained (in mM): 10 Tris, 10 β-mercap-
toethanol, with 1% SDS (pH 8.8). Sodium citrate strip-
ping buffer (SCSB) contained (in mM): 100 Na3C6H5O7
2H20, 10 β-mercaptoethanol, with 1% SDS; pH 3.0. Phos-
phate-buffered saline (PBS) contained (in mM): 136.9
NaCl, 2.7 KCl, 10.1 Na2HPO4, and 1.8 KH2PO4 (pH 7.4).
Human recombinant brain-derived neurotrophic factor
(rhBDNF) was purchased from Promega (Madison, WI).
All salts and other reagents were purchased from Sigma
Chemical Co. (St. Louis, MO) or Fisher Scientific (Atlanta,
GA).
cDNA constructs and antisera
All channel, kinase, and adaptor protein coding regions
were downstream from a cytomegalovirus (CMV) pro-BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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moter or a lac promoter. TrkB cDNA was a generous gift
from Dr. P. Barker, McGill University, in a CMX vector as
used previously [9]. A dead TrkB kinase (TrkBTrunc) and
a targeted mutation at the Shc binding site of TrkB (Y490
TrkB or TrkBShc-) were created by Dr. David Kaplan, Uni-
versity of Toronto, as described previously [37] and were
generous gifts to our study. Kv1.3 channel was subcloned
into the multiple cloning region of pcDNA3 (Invitrogen,
Carlsbad, CA) at the unique restriction HindIII site of the
multiple cloning region. The ten amino acid c-myc
epitope (EQKLISEEDL) was inserted into the extracellular
S1/S2 loop between residues 226–227 of Kv1.3 channel
via two consecutive polymerase chain reactions (PCRs)
using the Expand Long Template PCR System (Roche,
Indianapolis, IN). Both the untagged channel and
epitope-tagged version of the channel were used in this
study as required for surface expression and localization
experiments. We have previously demonstrated that the
tag does not alter channel biophysical properties or pro-
tein interactions [35]. Site-directed mutagenesis to gener-
ate Y to phenylalanine (F) at positions 111–113, 137,
449, and 479 was done as described previously [5,7]. The
cDNA for a non-conducting Kv1.3 mutant with a point
mutation exchanging a tryptophan (W) to F at position
386 was a generous gift from Dr. Todd Holmes (Univer-
sity of California Irvine, Irvine, CA) [38]. Neuronal Shc
(nShc) cDNA was a generous gift from Dr. T. Nakamura
(Sumitomo Electric Industries, Yokohama, Japan) and
was expressed in the vector pCMV1 [29]. Grb10 cDNA
was a gift from Dr. R. Roth (Stanford University) and was
expressed in pBlueScript SK (-) vector (Stratagene, La Jolla,
CA). Kv1.4 and Kv1.5 cDNA were both expressed in
pcDNA3 and were a generous gift from Todd Holmes
(University of California Irvine, Irvine, CA) [65].
AU13, a rabbit polyclonal antiserum, was generated
against a 46 amino acid sequence
(478MVIEEGGMNHSAFPQTPFKTGNSTATCTTNNNPND
CVNIKKIFTDV523) representing the unique coding
region of Kv1.3 on the C- terminus. Genemed Synthesis
(San Antonio, TX) purified the peptide and Cocalico Bio-
logicals (Reamstown, PA) the antisera as previously char-
acterized [36]. This antibody was used for
immunoprecipitation (1:1000) and Western blot detec-
tion (1:800) of Kv1.3. Kv1.4 and Kv1.5 polyclonal antis-
era were used for Western blot detection (1:1000) as
previously characterized and were generous gifts from
Drs. J.O. Dolly and T.C. Holmes, respectively [15]. Tyro-
sine phosphorylated proteins were visualized by the anti-
phosphotyrosine antibody 4G10 (Millipore/Upstate Bio-
chemical; St. Louis, MO) and used at 1:1000 for Western
blots. Tyrosine phosphorylated proteins were immuno-
precipitated with 4G10 antibody (3 μg per 600–1200 μg
of whole lysate protein). Monoclonal antiserum directed
against amino acids 156–322 of human TrkB was pur-
chased from BD Transduction Laboratories (San Jose, CA)
and used at 1:1000 for Western blots. Grb10 (K-20) rabbit
polyclonal antibody was purchased from Santa Cruz Bio-
technology, Inc. (Santa Cruz, CA) and used at 1:800 for
Western blots and at 1:500 for immunocytochemistry.
Shc rabbit polyclonal antibody (cat # 610082) from BD
Transduction Laboratories (San Jose, CA) was used for
immunohistochemistry (1:500) and Western blots
(1:750). Monoclonal actin antibody (A 2066) was pur-
chased from Sigma and used at 1:1000 for Western blots
as a secondary confirmation for equivalent protein load-
ing. Anti-c-myc mouse monoclonal (clone E910; antige-
netic peptide EQKLISEEDL against from the human myc
protein) was purchased from Roche and used at 1:800 for
Western blots. Donkey anti-rabbit FITC-conjugate (1:100)
and goat anti-rabbit Texas Red-conjugate (1:200) were
from Southern Biotech (Birmingham, AL).
Immunocytochemistry
Procedures for surface labeling of mycKv1.3 in the pres-
ence and absence of Grb10 as expressed in HEK293 cells
was as previously described [35]. Briefly, cells were
labeled under non-permeabilizing conditions to image
the surface distribution of the channel. Visualization and
microscopic analysis was performed on a Zeiss Axioplan 2
Microscope attached to a Zeiss LSM510 confocal system
(Carl Zeiss, Thornwood, NY) in conjunction with Meta-
morph software (Molecular Devices/Universal Imaging,
Dowingtown, PA). Samples were excited at 488 nm (for
GFP) and 595 nM (for Texas Red) through a 63× oil-
immersion objective (NA = 1.40) and fluorescence
between 500–545 and 565–615 nm was detected from
0.8 μm optical sections. Images were taken from the cells
at their maximum cross section. After removing back-
ground pixels by thresholding, integrated pixel intensity
was calculated both from the total cross section of the cell
and from an area that encompassed the cross section of
the cell excluding the outermost region.
Double-color immunofluorescence procedures for co-
localization of Kv1.3 channel and either Grb10 or nShc
adaptor protein in the olfactory bulb were as described in
Biju et al. [16]. Briefly, C57 BL/6 mice (postnatal day 20)
were anaesthetized with pentabarbitol, trancardially per-
fused, and post-fixed with 4% paraformaldehyde. Follow-
ing sucrose cryoprotection, olfactory bulbs were coronally
cut at 10 μm thickness on a Leica CM1850 microtome-cry-
ostat (Leica, Meyer Instruments, Houston, TX). Sections
were mounted on 2% gelatin coated slides and stored at -
20°C until immunoprocessing. Sequential labeling was
performed [16,35] using AU13 as the first primary anti-
body (visualized with FITC-conjugated, species-specific
secondary antibody), followed by anti-Shc or anti-Grb10
as the second primary antibody, which was visualized by
a Texas Red-conjugated, species-specific secondary anti-BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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body. Processed slides were viewed at 40× magnification
using an Axiovert S-100 Microscope (Carl Zeiss) equipped
with epifluorescence. Images were captured using an Axi-
ocam digital camera and Axiovision associated software
(v3.0.6) at a maximum pixel resolution of 1300 × 1300.
Maintenance and transfection of HEK 293 cells
HEK 293 cells were maintained in Minimum Essential
Medium (MEM), 2% penicillin/streptomycin, and 10%
FBS (Invitrogen/Gibco/BRL). Before transfection, cells
were grown to 100% confluency (7 days), dissociated
with trypsin-EDTA (Sigma) and mechanical trituration,
diluted in MEM to a concentration of 600 cells/ml, and
replated on Corning dishes (Catalog # 25000, Fisher Sci-
entific). The Corning dishes have a growing surface of
approximately 8 cm2 (electrophysiology) or 21 cm2 (bio-
chemistry) to favorably allow cells to divide logarithmi-
cally at the point of transfection. cDNA was introduced
into HEK 293 cells with a lipofectamine reagent (Invitro-
gen/Gibco/BRL) 3–5 days after passage as previously
described [7,8]. Briefly, cells were transfected for 4–5
hours with 0.5–0.75 μg of each cDNA construct per 35
mm dish for electrophysiology or 2–3.5 : μg of each cDNA
construct per 60 mm dish for biochemistry. Plasmid DNA
with no coding insert (control vector) served as the con-
trol to equalize total μg of cDNA added to each dish. Cells
were either harvested for biochemical analysis or used for
electrophysiological recordings approximately 30–40
hours after transfection. Efficiency of co-transfection
(greater than 95%) with our transfection method has
been tested using double, sequential labeling and confo-
cal microscopic visualization, as reported previously [8].
Immunoprecipitation and Electrophoretic Separation
Transfected cells were rinsed in PBS and then stimulated
with 10 ng/μl BDNF or vehicle control solution for ten
minutes at room temperature. The selection of vehicle
control (patch pipette solution), temperature, and incu-
bation time was designed to parallel conditions for bio-
chemistry with those used for electrophysiological
recordings. Cells were then harvested by lysis in ice-cold
PPI solution (see Solutions and Reagents). The lysates
were clarified by centrifugation at 14,000 × g for 10 min-
utes at 4°C and incubated for 1 hour (h) with 0.2–0.3 mg/
ml protein A-sepharose (GE Healthcare Bio-Sciences
Corp/Amersham-Pharmacia, Piscataway, NJ), followed by
re-centrifugation to remove the protein A-sepharose. To
test the phosphorylation state of Kv1.3 in the presence of
BDNF-activated TrkB kinase plus or minus an adaptor
protein, tyrosine-phosphorylated proteins were immuno-
precipitated from the clarified lysate by overnight incuba-
tion at 4°C with 3–4 μg/ml 4G10 antibody (Millipore/
Upstate Biochemical). Protein-protein interactions were
also determined by a similar co-immunoprecipitation
strategy by substituting 4G10 antibody for antisera
directed against Kv1.3, c-myc, Shc, Grb10, or TrkB kinase.
In experiments where tyrosine-phosphorylated proteins
were immunoprecipitated from native olfactory bulb or
hippocampus, tissues were harvested from postnatal day
20 (P20) C57BL/6 mice that had been euthanized via CO2
inhalation followed by decapitation according to AVMA-
and NIH-approved methods. Brain regions were quickly
removed from the cranium and homogenized 50 strokes
by Kontes tissue grinder (size 20) in homogenization
buffer on ice [8]. The lysate clarification, immunoprecipi-
tation, and SDS-PAGE analysis were as described for HEK
293 cells above. In experiments in which surface labeled
Kv1.3 was probed using c-myc antiserum, whole
mycKv1.3 transfected HEK 293 cells were first incubated
with c-myc antiserum (0.4 μg/μl) for 30 minutes at 37°C
prior to BDNF stimulation as above. Cells with surface-
labeled mycKv1.3 were then rinsed in PBS, lysed in ice-
cold PPI solution. Both immunoprecipitated proteins and
surface-labeled mycKv1.3 protein were harvested by a 2-h
incubation with protein A-sepharose and centrifugation
as above. The immunoprecipitates (IPs) were washed 3
times with ice-cold wash buffer (0.1% Triton). Lysates and
washed IPs were diluted in sodium dodecyl sulfate (SDS)
gel loading buffer containing 1 mM Na3VO4. Protein con-
centration was determined by Bradford protein assay
(Biorad Laboratories, Hercules, PA). Standard curves were
generated using the small percentage of Triton (final con-
centration of detergent = 0.001%) that did not signifi-
cantly interfer with protein concentration determination
in this assay. Proteins were separated on 10% acrylamide
SDS gels and electrophoretically transferred to nitrocellu-
lose for Western blot analysis. Nitrocellulose membranes
were blocked with 5% nonfat milk and incubated over-
night at 4°C in primary antibody against Kv1.3 or other
sought protein partner. Membranes were then exposed to
species-specific peroxidase-conjugated secondary (GE
Healthcare Bio-Sciences Corp/Amersham-Pharmacia or
Sigma) for 90 minutes at room temperature. Enhanced
chemiluminescence (ECL; GE Healthcare BioSciences
Corp/Amersham-Pharmacia) exposure of Fuji RX film
(Fisher Scientific) was used to visualize labeled protein.
In experiments comparing Kv1.3 expression in the pres-
ence and absence of Grb10 adaptor protein, labeled Kv1.3
bands from cell lysates were quantified by densitometry
using a Hewlett-Packard Photosmart Scanner in conjunc-
tion with Quantiscan software (Biosoft, Cambridge, UK).
Pixel densities for each band were normalized to Kv1.3
within the same cell passage, transfection, and autoradio-
graph. Mean pixel densities were then calculated across
sets of normalized data contained in single autoradio-
graphs. This type of quantification was designed to reduce
inherent variability in cell culture, transient transfection
efficiencies, and ECL exposure times. Statistical signifi-
cance was set at the 95% confidence level for immun-BMC Neuroscience 2009, 10:8 http://www.biomedcentral.com/1471-2202/10/8
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odensitometry data that were analyzed by one-way
analysis of variance (ANOVA) with Student Newman
Keuls (snk) follow-up test. In experiments comparing
Kv1.3 mutant expression in the presence of Grb10 adap-
tor protein, labeled Kv1.3 bands were quantified as above
and normalized to the channel mutant alone condition
within the same cell passage, transfection, and autoradio-
graph. Mean pixel densities were calculated as above, and
statistical significance was set at the 95% confidence level
for immunodensitometry data that were analyzed by Stu-
dent's t-test with an arcsine transformation for percentage
data.
Electrophysiology
Patch electrodes were fabricated from Jencons glass (Jen-
cons Limited, Bridgeville, PA), fire-polished to approxi-
mately 1 μm, and coated near the tip with beeswax to
reduce the electrode capacitance. Pipette resistances were
between 9 and 14 MΩ. Hoffman modulation contrast
optics was used to visualize cells at 40× magnification
(Axiovert 135, Carl Zeiss). Macroscopic currents in cell-
attached membrane patches were recorded using an Axo-
patch-200B amplifier (MDS Analytical Technologies/
Axon Instruments, Sunnyvale, CA), filtered at 2 kHz, dig-
itized at 2–5 kHz, and stored for later analysis. All voltage
signals were generated and data were acquired with the
use of an Axon Digidata 1200 board with pClamp soft-
ware (Axon Instruments). Data were analyzed using soft-
ware from Microcal Origin (Northampton, MA) and
Quattro Pro (Borland International, Scotts Valley, CA).
Outward macroscopic currents were recorded in the cell-
attached rather than whole-cell configuration; Kv1.3
channel expression is so robust in the HEK 293 expression
system that it is not routinely possible to record whole-cell
currents without saturating the amplifier [4-6]. Patches
were held routinely at a holding potential (Vh) of -90 mV
and stepped in 20 mV depolarizing potentials (Vc) using a
pulse duration of 1000 milliseconds. Pulses were gener-
ally delivered at intervals of 60 seconds or longer to pre-
vent cumulative inactivation of the Kv1.3 channel [66].
Kv1.3 peak current amplitude, channel inactivation (τin-
act) and deactivation (τdeact) kinetics, voltage at one-half
maximal activation (V1/2), and slope of voltage depend-
ence (κ) were measured in the presence of TrkB kinase and
the presence or absence of an adaptor protein (N-Shc or
Grb10). Each biophysical property was measured prior
and following BDNF stimulation using a blocked (within
cell patch) design as described previously [9,36]. Briefly,
BDNF stimulation was accomplished by tip-filling (~0.01
mm) the patch-pipette with control solution to acquire
the basal measurement (time 0) and then back filling
(~35 mm) with BDNF (1 ng/μl) to acquire the post-simu-
lation measurement (20 minutes). Each biophysical prop-
erty was analyzed in the form of non-normalized data by
blocked factorial, two-way ANOVA with a snk follow-up
test at the 95% confidence level to determine any statisti-
cal difference in Kv1.3 channel function in the presence of
kinase or adaptor proteins, with or without neurotrophin
stimulation. For graphical representations of peak current
amplitudes among different transfection conditions,
measurements were normalized to the transfection condi-
tion of Kv1.3 alone within a single recording session and
respective transfection set. Kinetic properties of Kv1.3
have been reported to be independent of current magni-
tude [66], thus peak current amplitude but not kinetic
data were normalized to adjust for differences in channel
expression between transfections.
Fitting parameters for inactivation and deactivation kinet-
ics were as previously described [8]. Briefly, the inactiva-
tion of the macroscopic current, during a 1000 ms voltage
step from -90 to +40 mV, was fit to the sum of two expo-
nentials by minimizing the sums of squares using a bi-
exponential function-(y = y0 + A1e-(x-x0)/τ1 + A2e-(x-x0)/τ2).
The two inactivation time constants (τ1 and τ2) were com-
bined by multiplying each by its weight (A) and sum-
ming. The summed inactivation rate was calculated with
the equation Tau Inactivation (τinact) = [A1 * τ1) + (A2 *
τ2)]/(A1 + A2). The deactivation of the macroscopic cur-
rent (τDeact) was fit similarly but to a single exponential (y
= y0+ Ae-(x-x0)/τ). Tail current amplitudes were plotted in a
current-voltage relationship and fit to a Boltzmann sig-
moidal curve (Y = [(A1 + A2)/(1 + e(x-x0)/dx)] + A2) to calcu-
late the slope of voltage dependence (κ) and voltage at
half-activation (V1/2) for Kv1.3.
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